Hep-pred: Hepatitis C staging prediction using fine gaussian SVM

90Citations
Citations of this article
81Readers
Mendeley users who have this article in their library.

Abstract

Hepatitis C is a contagious blood-borne infection, and it is mostly asymptomatic during the initial stages. Therefore, it is difficult to diagnose and treat patients in the early stages of infection. The disease’s progression to its last stages makes diagnosis and treatment more difficult. In this study, an AI system based on machine learning algorithms is presented to help healthcare professionals with an early diagnosis of hepatitis C. The dataset used for our Hep-Pred model is based on a literature study, and includes the records of 1385 patients infected with the hepatitis C virus. Patients in this dataset received treatment dosages for the hepatitis C virus for about 18 months. A former study divided the disease into four main stages. These stages have proven helpful for doctors to analyze the liver’s condition. The traditional way to check the staging is the biopsy, which is a painful and time-consuming process. This article aims to provide an effective and efficient approach to predict hepatitis C staging. For this purpose, the proposed technique uses a fine Gaussian SVM learning algorithm, providing 97.9% accurate results.

Cite

CITATION STYLE

APA

Ghazal, T. M., Anam, M., Hasan, M. K., Hussain, M., Farooq, M. S., Ali, H. M. A., … Soomro, T. R. (2021). Hep-pred: Hepatitis C staging prediction using fine gaussian SVM. Computers, Materials and Continua, 69(1), 191–203. https://doi.org/10.32604/cmc.2021.015436

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free